Skip to content

Aytu BioScience to manufacture Healight devices for COVID-19 studies

August 17, 2020

Aytu BioScience (NASDAQ:AYTU) rises ~8% in premarket, after the company announces delivery of Healight investigational devices, for use in upcoming COVID-19 clinical studies. The device is designed by Sterling Medical Devices.

The pilot scale devices employ proprietary methods of administering intermittent ultraviolet A light via a respiratory tract device.

Pre-clinical findings indicate the technology’s significant impact on reducing a range of viral and bacterial loads, including the coronavirus HCoV-229E.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: